The siRNA–FAK reduces theresistance of ovarian cancer cells to chemotherapy and paclitaxelinduces apoptosis in cancer cells.316 Effluxtransporters and Bcl-2 are the most common targets used to rendercancerous cells more susceptible to paclitaxel chemotherapy. The gene discussed is PTK2; the disease is ovarian cancer.